Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Role of Precision Medicine in Cardiovascular Disease
Jane A. Leopold, Joseph Loscalzo
Circulation Research (2018) Vol. 122, Iss. 9, pp. 1302-1315
Open Access | Times Cited: 275

Showing 26-50 of 275 citing articles:

Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart Failure
Tariq Ahmad, Nihar R. Desai, Yu Yamamoto, et al.
JAMA Cardiology (2022) Vol. 7, Iss. 9, pp. 905-905
Open Access | Times Cited: 41
Multiomics Network Medicine Approaches to Precision Medicine and Therapeutics in Cardiovascular Diseases
Rui‐Sheng Wang, Bradley A. Maron, Joseph Loscalzo
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 4, pp. 493-503
Open Access | Times Cited: 40
Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research
Zhenhua Li, Jun Wang, Jingping Xu, et al.
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 34
RNA modification in cardiovascular disease: implications for therapeutic interventions
Cong Wang, Xuyang Hou, Qing Guan, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 31
SGLT2 inhibitor ameliorates endothelial dysfunction associated with the commonALDH2alcohol flushing variant
Hongchao Guo, Xuan Yu, Yu Liu, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 680
Open Access | Times Cited: 30
Patients' perspectives related to ethical issues and risks in precision medicine: a systematic review
Lawko Ahmed, Anastasia Constantinidou, Andreas Chatzittofis
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 25
Artificial Intelligence in Heart Failure: Friend or Foe?
Angeliki Bourazana, Αndrew Xanthopoulos, Αlexandros Briasoulis, et al.
Life (2024) Vol. 14, Iss. 1, pp. 145-145
Open Access | Times Cited: 15
Effect of timed dosing of usual antihypertensives according to patient chronotype on cardiovascular outcomes: the Chronotype sub-study cohort of the Treatment in Morning versus Evening (TIME) study
Filippo Pigazzani, Kenneth A. Dyar, S. V. Morant, et al.
EClinicalMedicine (2024) Vol. 72, pp. 102633-102633
Open Access | Times Cited: 10
Genetic Testing and its Role in Precision Medicine: Understand Disease Risk and Tailoring Treatments
Zohorul Islam, Zainullah, Adil Khan, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 1, pp. 461-470
Closed Access | Times Cited: 1
Differential epigenetic factors in the prediction of cardiovascular risk in diabetic patients
Claudio Napoli, Giuditta Benincasa, Concetta Schiano, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2019) Vol. 6, Iss. 4, pp. 239-247
Open Access | Times Cited: 69
Discovery of an orally active VHL-recruiting PROTAC that achieves robust HMGCR degradation and potent hypolipidemic activity in vivo
Guoshun Luo, Zhenbang Li, Xin Lin, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 5, pp. 1300-1314
Open Access | Times Cited: 61
Clinical Knowledge Graph Integrates Proteomics Data into Clinical Decision-Making
Alberto Santos, Ana R. Colaço, Annelaura Bach Nielsen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 57
Human-induced pluripotent stem cells in cardiovascular research: current approaches in cardiac differentiation, maturation strategies, and scalable production
Dilip Thomas, Nathan James Cunningham, Sushma Shenoy, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 1, pp. 20-36
Open Access | Times Cited: 56
Next-Generation Personalized Medicine: Implementation of Variability Patterns for Overcoming Drug Resistance in Chronic Diseases
Yaron Ilan
Journal of Personalized Medicine (2022) Vol. 12, Iss. 8, pp. 1303-1303
Open Access | Times Cited: 37
Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure
Wouter Ouwerkerk, João Pereira, Troy Maasland, et al.
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 20, pp. 1921-1931
Open Access | Times Cited: 23
Genetic predictors of lifelong medication-use patterns in cardiometabolic diseases
Tuomo Kiiskinen, Pyry Helkkula, Kristi Krebs, et al.
Nature Medicine (2023) Vol. 29, Iss. 1, pp. 209-218
Open Access | Times Cited: 17
Bile Acids and Bilirubin Role in Oxidative Stress and Inflammation in Cardiovascular Diseases
Angela Punzo, Alessia Silla, Federica Fogacci, et al.
Diseases (2024) Vol. 12, Iss. 5, pp. 103-103
Open Access | Times Cited: 8
Stratified medicine for acute and chronic coronary syndromes: A patient-tailored approach
Rocco Antonio Montone, Thomas J. Ford, Mattía Galli, et al.
Progress in Cardiovascular Diseases (2024) Vol. 85, pp. 2-13
Open Access | Times Cited: 8
Strengths and Opportunities of Network Medicine in Cardiovascular Diseases
Giuditta Benincasa, Raffaele Marfella, Nunzia Della Mura, et al.
Circulation Journal (2019) Vol. 84, Iss. 2, pp. 144-152
Open Access | Times Cited: 53
Fluid-based assays and precision medicine of cardiovascular diseases: the ‘hope’ for Pandora’s box?
Giuditta Benincasa, Gelsomina Mansueto, Claudio Napoli
Journal of Clinical Pathology (2019) Vol. 72, Iss. 12, pp. 785-799
Open Access | Times Cited: 51
VHL-based PROTACs as potential therapeutic agents: Recent progress and perspectives
Chao Wang, Yujing Zhang, Jie Wang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113906-113906
Closed Access | Times Cited: 41
EAPC Core Curriculum for Preventive Cardiology
Matthias Wilhelm, Ana Abreu, Paolo Emilio Adami, et al.
European Journal of Preventive Cardiology (2021) Vol. 29, Iss. 1, pp. 251-274
Open Access | Times Cited: 40
Cyclic GMP modulating drugs in cardiovascular diseases: mechanism-based network pharmacology
Alexandra Petraina, Cristian Nogales, Thomas Krahn, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 9, pp. 2085-2102
Open Access | Times Cited: 38
Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine
Emanuele Micaglio, Emanuela H. Locati, Michelle M. Monasky, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 36
Liquid Biopsy for Patient Characterization in Cardiovascular Disease: Verification against Markers of Cytochrome P450 and P‐Glycoprotein Activities
Brahim Achour, Pauline Gosselin, Jean Terrier, et al.
Clinical Pharmacology & Therapeutics (2022) Vol. 111, Iss. 6, pp. 1268-1277
Open Access | Times Cited: 28

Scroll to top